News & Insights Across Asia
US oncologist Linda Bosserman praises the rapid advancement of medical services and pharmaceuticals in the Chinese mainland, calling for greater scientific cooperation.
China pioneers Parkinson’s treatment breakthroughs in 2026 through early detection tech, stem cell therapies, and holistic care models transforming patient outcomes.
Guangdong’s hospitals attract global patients with advanced care and competitive costs, fueled by policy support and tech innovation in China’s medical tourism sector.
China introduces a national long-term care insurance system to support elderly care, aiming for full coverage by 2028. A major step in addressing demographic challenges.
Peng Liyuan emphasizes China’s collaborative approach and global cooperation in combating tuberculosis, aligning with WHO’s 2026 World TB Day theme.
Peng Liyuan, WHO goodwill ambassador, calls for international collaboration to combat TB, highlighting China’s progress and volunteer efforts in disease control.
China’s medical regulator approves groundbreaking invasive brain-computer interface device, revolutionizing treatment for paralysis and neurological disorders.
China’s NMPA approves the world’s first invasive BCI device for spinal injury patients, marking a milestone in medical technology and future industry growth.
China’s 2026 healthcare reforms focus on strengthening public health infrastructure, integrating TCM, and improving medical insurance systems to enhance nationwide services.
Chinese hospitals debut AI-driven medical solutions at WHX2026, revealing 10% export growth to Middle Eastern markets and new smart hospital technologies.
Chinese doctors pioneer artificial hearts as long-term support systems, achieving 85% one-year survival rates through advanced postoperative management.
Despite losing his voice, Cai Lei’s AI-driven advocacy has accelerated ALS research in China, yielding 40 clinical pipelines and over 200 treatments. His legacy inspires a new chapter in medical collaboration.
A new documentary explores China’s ICU advancements, blending cutting-edge technology with human-centered care in critical medicine. #Healthcare #China
China sees 77% of new organ donor registrations from young adults in 2024, driving record transplant numbers and international medical cooperation.
Tianjin issues its first medical license to a wholly foreign-owned hospital, marking a pivotal step in China’s healthcare openness.
China reduces average diagnosis time for rare diseases from four years to less than four weeks, transforming patient lives and setting new standards in global healthcare.
Hainan Province is easing the financial burden of childbirth by covering labor pain relief under health insurance, doubling the number of women opting for the procedure and promoting a childbirth-friendly environment.
China’s drug price negotiation program has saved patients over 880 billion yuan ($112.4 billion) as of October 2024, according to the NHSA, highlighting efforts to make medicines more affordable.
China’s expanded drug coverage through price negotiations has saved patients over 880 billion yuan as of October 2024, according to the National Healthcare Security Administration.
Global medical companies are unveiling innovative technologies at the China International Import Expo, highlighting China’s pivotal role in global healthcare and the growing importance of its market.
